Skip to main content

Probiotics Expand Beyond GI: Emotional Wellness Surges 160%

Jessie Wang By Jessie Wang 5 min read

Executive Summary#

In Jan-Sep 2025, probiotic sales extended beyond core GI health into oral care, emotional wellness and irritable bowel syndrome (IBS) management. Online sales of emotional wellness probiotics rose 160.2% year on year to CN¥ 145.6 million, as consumer interest in mental wellness and in the link between gut and mood grew. These newer uses give brands room to stand out as probiotics become an everyday wellness product.

Download Full Report#

Get the complete analysis with additional data, methodology details, and brand-level insights.

Download the Full H1 2025 GI Health Supplements Whitepaper →

Oral Care Probiotics: Dual-Benefit Positioning#

The oral care probiotics segment reached CN¥ 307.9 million, up 11.8% year on year, helped by products positioned for both digestive health and fresh breath. This combination appeals to professional and social scenarios where oral freshness directly impacts confidence and interactions.

It is the largest of the three expanded-application segments, although it grew the slowest. A small number of brands account for the bulk of segment sales while each of the rest holds a low single-digit share, which leaves room for challenger brands with different formulations.

Oral care is the largest expanded-application probiotic segment

Oral care is the largest expanded-application probiotic segment

*Source: Moojing Market Intelligence*

Key success factors in oral care probiotics include:

  • Breath management claims validated by consumer experience
  • Convenient formats for on-the-go consumption
  • Dual positioning connecting oral health to overall wellness
  • Professional scenario marketing targeting workplace consumers

Emotional Wellness: The Gut-Brain Axis Opportunity#

Emotional wellness was the fastest-growing of the three expanded-application segments, which we believe reflects rising awareness of mental wellness and growing consumer acceptance of a link between gut health and mood.

The segment has an established front-runner but no settled order beneath it. Brands in the segment compete mainly on how they explain the science behind their formulations, which leaves an opening for those that can point to published research on their strains.

Emotional wellness leads expanded-application growth at +160% YoY

Emotional wellness leads expanded-application growth at +160% YoY

*Source: Moojing Market Intelligence*

IBS Management: Specialized Segment Growth#

The IBS management segment grew 62.2% year on year to CN¥ 43.5 million. It is the smallest and most fragmented of the three expanded applications, with no brand holding a commanding position, and brands compete mainly on the research behind their strains.

Shoppers in this segment know more about probiotic strains than most and are willing to pay more for products backed by published research.

Scenario-Based Consumption Patterns#

Social media analysis reveals probiotics evolving from pure GI health products into all-round, scenario-based health companions. Key consumption scenarios include work environments and business travel, where portable products combining GI care and oral freshening address invisible needs for professional settings.

Work and travel scenarios lead probiotic mentions with 68K discussions each

Work and travel scenarios lead probiotic mentions with 68K discussions each

*Source: Moojing Market Intelligence*

Sales of probiotics for work and travel reached CN¥ 13.6 million, up 67.6% year on year, while units rose 43.1%. Consumers associate business trips and commutes with digestive discomfort, which creates demand for portable products made for those occasions.

GLP-1 Probiotic Delivery: Next-Generation Innovation#

Some companies are developing oral probiotics engineered to release GLP-1, the gut hormone that weight-loss injections mimic, which would let them sell a GLP-1 product outside the pharmaceutical market.

GLP-1 sales climb to CN¥ 290 million by September 2025

GLP-1 sales climb to CN¥ 290 million by September 2025

*Source: Moojing Market Intelligence*

GLP-1 sales reached CN¥ 290 million in September 2025. Consumer conversation about GLP-1 grew alongside sales, which drew supplement brands into a category once left to pharmaceutical companies. That creates an opening for probiotic-based delivery systems positioned as oral alternatives to injectable GLP-1 medications.

Flavor Innovation for Mass Market Reach#

Taste ranks as consumers' third most important consideration after efficacy and side effects. Products that cannot deliver pleasant taste experiences face competitive disadvantage in reaching mass markets. Probiotic snacks are the main route to younger consumers, because they make probiotics easier to take and better tasting.

Successful flavor innovations include:

  • Combinations with superfoods and trendy flavors
  • Probiotic condiments and ice cream formats
  • Probiotic cookies and other baked formats earning strong taste and texture feedback
  • Probiotics as value-add rather than core product perception

About the Data#

This analysis draws on Moojing Market Intelligence data covering Jan-Sep 2025. Moojing analyses brand and category performance across major Chinese e-commerce platforms. For full methodology and additional insights, see the complete GI Health Supplements whitepaper.

This content adheres to Moojing's editorial standards .

Share this article

Need Deeper APAC Market Intelligence?

Our research team can provide custom data and analysis tailored to your business needs.

MoInsights, sent directly to your inbox.

Sign up for our newsletter for the latest ecommerce and product insights, analysis and more.

By clicking the "Continue" button, you are agreeing to Moojing's Privacy Policy .